Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Capuron, L. Articles by Miller, A. H. Search for Related Content PubMed Citation Articles by Capuron, L. Articles by Miller, A. H. Neuroendocrinology Depression

Association of Exaggerated HPA Axis Response to the Initial Injection of Interferon-Alpha With Development of Depression During Interferon-Alpha Therapy

OBJECTIVE: The authors assessed the relationship between the hypothalamic-pituitary-adrenal (HPA) axis response to interferon-alpha (IFN-) and the development of major depression during IFN- treatment. METHOD: Adrenocorticotropic hormone (ACTH), cortisol, and interleukin-6 (IL-6) plasma concentrations were measured in 14 patients with malignant melanoma at regular intervals during the first 12 weeks of IFN- therapy, both immediately before and 1, 2, and 3 hours after IFN- administration. Symptom criteria for major depression were also evaluated at each visit. RESULTS: ACTH and cortisol responses but not IL-6 responses to the initial administration of IFN- were significantly higher in the seven patients who subsequently developed symptom criteria for major depression than in those who did not. No differences in hormonal or cytokine responses were found between these two groups during chronic IFN- administration. CONCLUSIONS: The HPA axis response to the acute administration of IFN- reveals a vulnerability to IFN--induced depression, possibly due to sensitization of corticotropin-releasing factor pathways.

This article has been cited by other articles:

				K. M. Nautiyal, A. C. Ribeiro, D. W. Pfaff, and R. Silver Brain mast cells link the immune system to anxiety-like behavior PNAS, November 18, 2008; 105(46): 18053 - 18057. [Abstract] [Full Text] [PDF]

				C-W. Tsao, Y-S. Lin, J-T. Cheng, C-F. Lin, H-T. Wu, S-R. Wu, and W-H. Tsai Interferon-{alpha}-induced serotonin uptake in Jurkat T cells via mitogen-activated protein kinase and transcriptional regulation of the serotonin transporter J Psychopharmacol, September 1, 2008; 22(7): 753 - 760. [Abstract] [PDF]

				A. H. Miller, S. Ancoli-Israel, J. E. Bower, L. Capuron, and M. R. Irwin Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer J. Clin. Oncol., February 20, 2008; 26(6): 971 - 982. [Abstract] [Full Text] [PDF]

				A. H. Miller and C. L. Raison Immune System Contributions to the Pathophysiology of Depression Focus, January 1, 2008; 6(1): 36 - 45. [Abstract] [Full Text] [PDF]

				J. E. Dimsdale and R. Dantzer A Biological Substrate for Somatoform Disorders: Importance of Pathophysiology Psychosom Med, November 1, 2007; 69(9): 850 - 854. [Abstract] [Full Text] [PDF]

				A. P. Mundt, R. Sarkar, C. Winter, M. Schaefer, and A. Strohle Exacerbation of Psychogenic Movement Disorder by Interferon{alpha} Treatment of Hepatitis C Psychosomatics, February 1, 2007; 48(1): 86 - 87. [Full Text] [PDF]

				Y. Horsmans Interferon-induced depression in chronic hepatitis C J. Antimicrob. Chemother., October 1, 2006; 58(4): 711 - 713. [Abstract] [Full Text] [PDF]

				C. C. Crone, G. M. Gabriel, and A. DiMartini An Overview of Psychiatric Issues in Liver Disease for the Consultation-Liaison Psychiatrist Psychosomatics, June 1, 2006; 47(3): 188 - 205. [Abstract] [Full Text] [PDF]

				L. A. Mistler, M. F. Brunette, B. J. Marsh, R. M. Vidaver, R. Luckoor, and S. D. Rosenberg Hepatitis C treatment for people with severe mental illness. Psychosomatics, March 1, 2006; 47(2): 93 - 107. [Abstract] [Full Text] [PDF]

				Y Tache Corticotropin releasing factor receptor antagonists: potential future therapy in gastroenterology? Gut, July 1, 2004; 53(7): 919 - 921. [Full Text] [PDF]

				Perspectives on Neuroscience and Behavior Neuroscientist, December 1, 2003; 9(6): 430 - 431. [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us